Opiold and nociceptin receptors regulate cytokine and cytokine receptor expression

被引:98
作者
Finley, M. J. [1 ,4 ]
Happel, C. M. [1 ,4 ]
Kaminsky, D. E. [2 ,4 ]
Rogers, T. J. [1 ,3 ,4 ]
机构
[1] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA
[2] Temple Univ, Sch Med, Dept Microbiol & Immunol, Philadelphia, PA 19140 USA
[3] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA
[4] Temple Univ, Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA
基金
美国国家卫生研究院;
关键词
opioid; opioid receptors; chemokine; chemokine receptors; cytokine; nociceptin; GPCR; HIV; ORLI;
D O I
10.1016/j.cellimm.2007.09.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Opioids were originally discovered because of their ability to induce analgesia, but further investigation has shown that the opioids regulate the function of cells involved in the immune response. We suggest that the regulation of cytokine, chemokine, and cytokine receptor expression is a critical component of the immunomodulatory activity of the opioids. In this paper we review the literature dealing with the regulation of cytokine and cytokine receptor expression by agonists for the three major opioid receptor types (mu, kappa, and delta), and nociceptin, the natural agonist for the orphanin FQ/nociceptin receptor. Although the opioid receptors share a high degree of sequence homology, opposing roles between the kappa opioid receptor (KOR) and the mu opioid receptor (MOR) have become apparent. We suggest that activation of the KOR induces an anti-inflammatory response through the down-regulation of cytokine, chemokine and chemokine receptor expression, while activation of the MOR favors a pro-inflammatory response. Investigation into the opioid receptor-like (ORL1)/nociceptin system also suggests a role for this receptor as a down-regulator of immune function. These effects suggest a broad role for opioids in the modulation of the function of the immune system, and suggest possible targets for the development of new therapeutics for inflammatory and infectious diseases. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:146 / 154
页数:9
相关论文
共 96 条
[71]   Modulation of Immune Function by Morphine: Implications for Susceptibility to Infection [J].
Roy, Sabita ;
Wang, Jinghua ;
Kelschenbach, Jennifer ;
Koodie, Lisa ;
Martin, Josephine .
JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2006, 1 (01) :77-89
[72]   Cutting edge:: Nociceptin stimulates neutrophil chemotaxis and recruitment:: Inhibition by aspirin-triggered-15-epi-lipoxin A4 [J].
Serhan, CN ;
Fierro, IM ;
Chiang, N ;
Pouliot, M .
JOURNAL OF IMMUNOLOGY, 2001, 166 (06) :3650-3654
[73]  
SHAHABI NA, 1995, ADV EXP MED BIOL, V373, P29
[74]   BETA-ENDORPHIN BINDING TO NALOXONE-INSENSITIVE SITES ON A HUMAN MONONUCLEAR CELL-LINE (U937) - EFFECTS OF CATIONS AND GUANOSINE TRIPHOSPHATE [J].
SHAHABI, NA ;
PETERSON, PK ;
SHARP, B .
ENDOCRINOLOGY, 1990, 126 (06) :3006-3015
[75]   Detection of basal levels and induction of delta opioid receptor mRNA in murine splenocytes [J].
Sharp, BM ;
Shahabi, N ;
McKean, D ;
Li, MD ;
McAllen, K .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 78 (1-2) :198-202
[76]   U50,488 inhibits HIV-1 Tat-induced monocyte chemoattractant protein-1 (CCL2) production by human astrocytes [J].
Sheng, WS ;
Hu, SX ;
Lokensgard, JR ;
Peterson, PK .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (01) :9-14
[77]   μ-opioid modulation of HIV-1 coreceptor expression and HIV-1 replication [J].
Steele, AD ;
Henderson, EE ;
Rogers, TJ .
VIROLOGY, 2003, 309 (01) :99-107
[78]   Identification of opioid-regulated genes in human lymphocytic cells by differential display: upregulation of Kruppel-like factor 7 by morphine [J].
Suzuki, S ;
Chuang, LF ;
Doi, RH ;
Chuang, RY .
EXPERIMENTAL CELL RESEARCH, 2003, 291 (02) :340-351
[79]   Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: Induction of CC chemokine receptor 5 expression for virus entry [J].
Suzuki, S ;
Chuang, AJ ;
Chuang, LF ;
Doi, RH ;
Chuang, RY .
JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (12) :1826-1829
[80]  
SZABO I, 1993, J PHARMACOL EXP THER, V267, P703